SEC Form 4 · accession 0001571049-15-006886

PHIBRO ANIMAL HEALTH CORP · PAHC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

10% Owner

Period of report

Aug 17, 2015

Accepted (ET)

Aug 19, 2015 · 9:01 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001069899

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Class A Common Stock^F1,F2	Aug 17, 2015	S	6,000	$36.762	D	55,343	D
Class A Common Stock^F3	Aug 18, 2015	C	22,675	—	A	78,018	D
Class A Common Stock^F1,F4	Aug 18, 2015	S	6,000	$37.761	D	72,018	D
Class A Common Stock^F1,F5	Aug 19, 2015	S	6,000	$36.911	D	66,018	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Class B Common Stock^F3	—	Aug 18, 2015	C	22,675	D	—	—	Class A Common Stock	22,675	21,185,793	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 16, 2015.
F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.02 to $37.86, inclusive.
F3The Class B Common Stock was convertible into Class A Common Stock at any time on a one-for-one basis, and had no expiration date.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.25 to $38.36, inclusive.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.16 to $37.41, inclusive.